Clinical trial evaluating Moderna s COVID-19 variant vaccine starts in US chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.
Covid-19 has changed the way many people live and work. It has also had an impact on the ways many scientists collaborate and carry out their research – and how they release their findings.
The need for speed in the fast-changing research landscape of the pandemic put pressure on biomedical researchers to share their work as fast as possible.
Many communicated their findings using preprints for the first time, releasing research reports that have not been thoroughly reviewed.
By putting these preprints into non-profit online libraries – preprint servers – that do not charge for access, they could get their results out far quicker than if they had been given a thorough review and published in a traditional journal. That process that could take more than a year.
Apr 1, 2021
LONDON/CHICAGO – The rapid rise in various parts of the world of deadly, more infectious COVID-19 variants that share new mutations is leading scientists to ask a critical question has the SARS-CoV-2 virus shown its best cards?
New variants first detected in such far-flung countries as Brazil, South Africa and the U.K. cropped up spontaneously, within a few months, late last year. All three share some of the same mutations in the important spike region of the virus used to enter and infect cells.
These include the E484k mutation, nicknamed “Eek” by some scientists for its apparent ability to evade natural immunity from previous COVID-19 infection and to reduce the protection offered by current vaccines all of which target the spike protein.
Scientist.com Partners with Top CROs to Offer Disease Models for Cancer Research
AI-powered Disease Model Finder helps researchers identify preclinical oncology models
Scientist.com, the pharmaceutical industry s leading marketplace for life science research, announced today that it has partnered with Charles River, Certis Oncology and other leading oncology CROs to launch a Disease Model Finder that helps medical researchers use genetic, cellular and patient data to find the most appropriate research models for their preclinical development projects. Our proprietary model selection software uses multiple machine learning algorithms to help researchers sift through large amounts of data and identify in vitro and in vivo models for their research, stated Javier Pineda, PhD, Data Scientist at Scientist.com. Scientists can filter by gene mutation, gene expression, cancer type or patient information, and then purchase without delay once the right model is identified.
France s Macron addresses country on COVID-19 situation eureporter.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eureporter.co Daily Mail and Mail on Sunday newspapers.